RAJU PRASAD plan to sell securities of CRISPR THERAPEUTICS AG under Form 144

RAJU PRASAD filed Form 144 to notify SEC of plan to sell 10000 units of CRISPR THERAPEUTICS AG securities around 2025-12-22, with aggregate market value of $559,548.00. The total outstanding units is 95300233.0. The amount planned to be sold represents 0.01% of total outstanding units;